During the past decade, South Tyneside District Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Tyneside District Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Newcastle-upon-Tyne Hospitals NHS Trust" with 2 trials sponsored, "South Tyneside and Sunderland NHS Foundation Trust" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "Velindre NHS Trust" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Tyneside District Hospital" #1 collaborator was "ARC Medical Design Ltd" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Barnet and Chase Farm Hospitals NHS Trust" with 1 trials as a collaborator and "Berry Consultants" with 1 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "South Tyneside District Hospital" are "Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials) and "Adenoma" (1 trials). Many other conditions were trialed in "South Tyneside District Hospital" in a lesser frequency.

Most popular intervention types in "South Tyneside District Hospital" are "Drug" (10 trials), "Biological" (5 trials), "Other" (5 trials), "Procedure" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "quality-of-life assessment" (2 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials) and "Anakinra" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Tyneside District Hospital" are 16 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "South Tyneside District Hospital". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in South Tyneside District Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South Tyneside District Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".